Slide 1Current Treatment Options in MDS Dick Wells MD, DPhil, FRCPC Director, Crashley Myelodysplastic Syndrome Research Laboratory Odette Cancer Centre Slide 2 Tale of Two…
Clinical perspectives in higher risk MDS and AML with del 5q Lionel Adès Lenalidomide Combined to AZA in Higher Risk MDS with Del 5q A Study by the Groupe Francophone…